Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-23 | New | $30,531,749 | $30,531,749 | Equity Only | 06b | SEC link |
| 2025-03-21 | New | $7,485,000 | $7,485,000 | Debt Only | 06b | SEC link |
| 2024-06-10 | New | $6,040,000 | $6,040,000 | Debt Only | 06b | SEC link |
| 2022-10-17 | New | $15,684,004 | $15,684,004 | Equity Only | 06b | SEC link |
| 2021-07-08 | Amended | $13,500,000 | Unknown | Equity Only | SEC link | |
| 2021-06-24 | New | $13,500,000 | $13,500,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Thomas Barton | Director |
| Chrystyna Bedrij | Director |
| James Huang | Director |
| Michael Muhonen | Director |
| Laurie Platek | Director |
| Laurie Playtek | Executive |
| Mark Pykett | Director, Executive |
| Adrian Stecyk | Director, Executive |
| Fay Xing | Director |
| Debra Yu | Director |